Pharmaceutical companies in the United States by short interest

Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.

TG Therapeutics leads the 44 pharmaceutical companies in the United States ranked by short interest, at 19.0%, ahead of Rhythm Pharmaceuticals (16.8%) and Dianthus Therapeutics (16.5%). Figures as of the 30 Oct 2026 settlement date, from FINRA's short interest report, with shares outstanding from Yahoo Finance quotes.

Key facts

Companies ranked
44
First
TG Therapeutics19.0%
Median
7.16%
Combined market value
$3.81T
Countries
1

Market values as of .

United States
All sectors
Pharmaceuticals
USD
Clear filters
Pharmaceutical companies in the United States by short interest
#CompanyShort interest % ↓Market capPriceToday1 yearPrice, 30 daysCountry
1TG TherapeuticsTGTX · Health Care19.0%$10B$66.12 5.44% up 107% up United States
2Rhythm PharmaceuticalsRYTM · Health Care16.8%$8.3B$119.04 2.08% up 13% up United States
3Dianthus TherapeuticsDNTH · Health Care16.5%$4.7B$83.98 3.45% down 113% up United States
4Protagonist TherapeuticsPTGX · Health Care15.7%$8.3B$127.16 2.00% up 46% up United States
5Praxis Precision MedicinesPRAX · Health Care15.1%$8.5B$305.19 0.04% up 61% up United States
6CytokineticsCYTK · Health Care12.9%$7.1B$51.32 0.64% down 20% down United States
7Ionis PharmaceuticalsIONS · Health Care12.7%$4.6B$27.39 1.59% up 64% down United States
8Ligand PharmaceuticalsLGND · Health Care12.3%$6B$298.71 1.67% up 43% up United States
9Spyre TherapeuticsSYRE · Health Care12.2%$9.6B$101.46 8.15% up 286% up United States
10Edgewise TherapeuticsEWTX · Health Care11.6%$4.5B$41.37 1.59% down 88% up United States
11BridgeBio PharmaBBIO · Health Care10.7%$15.2B$78.01 1.58% up 17% up United States
12ErascaERAS · Health Care10.6%$4.8B$13.76 0.94% down 403% up United States
13Cogent BiosciencesCOGT · Health Care10.0%$4.8B$27.81 0.14% down 20% down United States
14Mirum PharmaceuticalsMIRM · Health Care9.99%$6B$92.49 0.59% up 31% up United States
15Travere TherapeuticsTVTX · Health Care9.96%$4.8B$50.24 1.68% down 44% up United States
16Oruka TherapeuticsORKA · Health Care9.53%$6.5B$95.74 0.60% down 241% up United States
17PTC TherapeuticsPTCT · Health Care9.31%$5B$60.23 0.22% down 20% down United States
18Madrigal PharmaceuticalsMDGL · Health Care9.20%$9.2B$398.08 5.67% down 24% down United States
19Corcept TherapeuticsCORT · Health Care8.34%$7.4B$67.79 3.25% down 8% down United States
20Arrowhead PharmaceuticalsARWR · Health Care8.19%$6.1B$43.11 0.28% up 10% up United States
21VeradermicsMANE · Health Care8.03%$5.3B$124.86 0.62% down 233% up United States
22BioMarin PharmaceuticalBMRN · Health Care7.29%$11.9B$61.43 4.99% up 11% up United States
23Definium TherapeuticsDFTX · Health Care7.02%$4B$29.12 0.88% down 169% up United States
24Elanco Animal HealthELAN · Health Care6.59%$13.3B$26.70 3.29% up 20% up United States
25InsmedINSM · Health Care6.42%$26.3B$119.80 1.69% down 40% down United States
26Axsome TherapeuticsAXSM · Health Care6.20%$7B$134.00 1.43% down 7% down United States
27Legend BiotechLEGN · Health Care6.13%$3.2B$16.25 0.87% up 42% down United States
28Summit TherapeuticsSMMT · Health Care5.28%$8.4B$10.50 1.59% down 36% down United States
29United TherapeuticsUTHR · Health Care4.31%$24.6B$577.34 1.16% down 23% up United States
30ZoetisZTS · Health Care4.12%$34.8B$85.57 2.50% up 29% down United States
31Alnylam PharmaceuticalsALNY · Health Care4.08%$20B$149.40 4.54% down 66% down United States
32Belite BioBLTE · Health Care3.40%$6.3B$156.23 0.94% down 31% up United States
33Amneal PharmaceuticalsAMRX · Health Care3.27%$7.6B$21.88 3.60% up 83% up United States
34ViatrisVTRS · Health Care3.07%$23.3B$20.28 0.83% down 96% up United States
35PfizerPFE · Health Care2.36%$159.9B$28.06 1.44% down 14% up United States
36Bristol-Myers SquibbBMY · Health Care2.29%$121.7B$59.56 2.92% down 34% up United States
37Royalty PharmaRPRX · Health Care2.27%$39.5B$68.67 0.01% down 78% up United States
38Regeneron PharmaceuticalsREGN · Health Care2.14%$97.8B$945.53 1.28% down 36% up United States
39Vertex PharmaceuticalsVRTX · Health Care1.90%$136B$536.45 0.42% up 27% up United States
40Abbott LaboratoriesABT · Health Care1.10%$181B$104.48 0.22% down 17% down United States
41Merck & CoMRK · Health Care1.08%$339.7B$137.78 3.90% down 51% up United States
42AbbVieABBV · Health Care0.89%$505.6B$286.01 2.33% down 26% up United States
43Eli LillyLLY · Health Care0.81%$1.23T$1,382.75 2.32% down 35% up United States
44Johnson & JohnsonJNJ · Health Care0.71%$656.5B$272.70 2.15% down 38% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; short interest from FINRA, the owner and source of the data, as of the 30 Oct 2026 settlement date.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Source: FINRA. Short interest is the shares sold short and not yet covered as brokers reported them to FINRA for the 30 Oct 2026 settlement date; FINRA publishes it about seven business days later, so it is not today's figure. It is divided by shares outstanding worked out as the market value over the share price, both from the same quote — not by the float, so the percent reads lower than a percent of float would. For a company with more than one class of shares the market value covers every class, which lowers it further.

Questions and answers

Which pharmaceutical companies in the United States rank first by short interest?

TG Therapeutics (19.0%), Rhythm Pharmaceuticals (16.8%) and Dianthus Therapeutics (16.5%) are the top three of the 44 pharmaceutical companies in the United States ranked by short interest as of the 30 Oct 2026 settlement date.

How many pharmaceutical companies in the United States are in this ranking?

44 are ranked by short interest.

What are these pharmaceutical companies in the United States worth together?

The 44 pharmaceutical companies in the United States ranked by short interest have a combined market value of $3.81T as of the 30 Oct 2026 settlement date.

What does ranking by short interest measure?

Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.

Cite this page

Funkfolio, “Pharmaceutical companies in the United States by short interest”, data as of 19 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?country=united-states&by=short-interest

Underlying data: FINRA short interest (the 30 Oct 2026 settlement date); Yahoo Finance.